Air Pollution’s Hidden Cancer Toll: Morocco Maps Where Fine Particles Hit Hardest

In a country better known for its Atlantic breezes and Saharan dunes than for toxic air, a new national assessment has revealed a stark and unsettling geography of risk. Researchers from Ibn Zohr University and partner institutions across Morocco have produced the first nationwide spatial analysis of lung cancer cases attributable to long-term exposure to fine particulate matter, known as PM2.5, and their findings redraw the map of environmental health concern in North Africa. Using the World Health Organization’s AirQ+ model, the team estimated that in the most polluted districts, nearly a quarter of lung cancer cases can be traced to the air residents breathe, while in the cleanest coastal areas the attributable share falls to just over two percent. The study, published in Environmental Monitoring and Assessment, is among the most detailed attempts yet to quantify how unevenly the burden of air pollution is distributed across a single nation.

PM2.5 refers to particles with a diameter of 2.5 micrometers or less, roughly one-thirtieth the width of a human hair. Because of their tiny size, these particles evade the respiratory system’s natural defenses, penetrating deep into the alveoli of the lungs and even crossing into the bloodstream. Once lodged in lung tissue, they trigger chronic inflammation, generate reactive oxygen species that damage DNA, and interfere with cellular repair mechanisms, a cascade of biological insults that epidemiological studies worldwide have linked to elevated rates of lung cancer, cardiovascular disease, and premature death. The International Agency for Research on Cancer classified outdoor air pollution as a Group 1 human carcinogen in 2013, and subsequent cohort studies across Europe, North America, and Asia have consistently confirmed that long-term exposure to even modest PM2.5 concentrations raises lung cancer risk in a roughly linear fashion, with no clearly identified safe threshold.

To translate this global evidence into local numbers, the Moroccan team applied the AirQ+ software tool developed by the WHO Regional Office for Europe. The model works by combining three ingredients: measured or estimated concentrations of a pollutant, the size of the exposed population, and a concentration-response function derived from large epidemiological cohorts. From these inputs it computes the relative risk, the attributable proportion, and the absolute number of health outcomes that can be ascribed to the pollutant, complete with 95 percent confidence intervals that reflect the statistical uncertainty of the underlying risk functions. The researchers fed the model with PM2.5 concentration data for 2019 covering 46 urban and rural districts spanning Morocco’s remarkably diverse geography, from humid Atlantic coastal plains to arid pre-Saharan valleys, and paired each concentration estimate with district-level population figures and lung cancer baseline incidence.

The results exposed a fourfold spread in exposure across the country. At the clean end of the spectrum sat El Jadida, a coastal city southwest of Casablanca, where PM2.5 averaged just 7.1 micrograms per cubic meter, well within reach of the WHO guideline of 5 micrograms per cubic meter for annual exposure. There, the calculated relative risk of lung cancer was a modest 1.02, with an attributable proportion of 2.35 percent. At the opposite extreme lay Errachidia, a southern oasis city on the edge of the Sahara, where concentrations reached 28.4 micrograms per cubic meter. The relative risk there climbed to 1.30, and the model attributed a striking 23.29 percent of lung cancer cases to particulate pollution, meaning nearly one in four diagnoses in that district could be linked to the air. Between these poles, the team identified other hotspots, including Ouarzazate at 20.2 micrograms per cubic meter with an attributable proportion of 15.82 percent, and Taourirt at 19.0 micrograms per cubic meter with 14.67 percent.

Perhaps the most counterintuitive finding concerns Morocco’s largest metropolises. Casablanca, the country’s economic engine and home to millions, recorded only a moderate relative risk of 1.06, with a 95 percent confidence interval of 1.04 to 1.08. Yet because of the sheer size of its population, the city accounted for a substantial number of attributable lung cancer cases, with the model estimating 24 cases linked to PM2.5 exposure. This distinction between relative risk and absolute burden is a cornerstone of environmental health statistics: a small percentage increase applied to a very large population can produce more disease than a large percentage increase applied to a small one. For policymakers, it means that intervention priorities cannot be set by concentration levels alone; both the toxicity of the local airshed and the number of people breathing it must enter the calculus.

Equally revealing is the divergence in pollution sources the study identified between urban and rural Morocco. In major urban centers, the dominant contributors are vehicular traffic and industrial emissions, the familiar cocktail of diesel exhaust, brake and tire wear, construction dust, and factory plumes that characterizes rapidly growing cities across the developing world. In contrast, several of the highest-exposure districts were rural or small-town areas in the interior and south, where the signature points instead to residential biomass combustion, the burning of wood, charcoal, and other solid fuels for heating and cooking, compounded in some regions by dust from arid landscapes and unpaved roads. This urban-rural split matters because it demands different remedies: traffic restrictions, fuel standards, and industrial emission controls in cities, versus cleaner household energy, improved stoves, and land management in the countryside. A single national air quality policy, the findings suggest, would miss the mark in both settings.

The broader scientific context reinforces the urgency of these numbers. Meta-analyses pooling cohort studies from multiple continents have estimated that each 10 microgram per cubic meter increment in long-term PM2.5 exposure raises lung cancer risk by roughly 8 to 10 percent, and recent large-scale projects such as the European ELAPSE consortium have shown that these risks persist and may even steepen at concentrations well below current European Union limits. Mechanistic work published in recent years has fleshed out the biological plausibility, documenting how fine particles promote tumorigenesis through oxidative stress, epigenetic alterations, and chronic activation of inflammatory pathways in lung epithelial cells. In the Middle East and North Africa region, where lung cancer remains a leading cause of cancer death and tobacco smoking compounds the pollution burden, locally grounded risk estimates have been conspicuously scarce, making the Moroccan assessment a template for neighboring countries facing similar data gaps.

The study’s authors frame their results as direct input for Morocco’s National Cancer Prevention Plan, and the policy implications are concrete. The southern regions and specific rural districts flagged as priority zones, including Errachidia, Ouarzazate, and Taourirt, would benefit first from strengthened air quality monitoring networks, which remain sparse outside the largest cities, and from source-targeted mitigation strategies addressing the dominant local emitters. Aligning national ambient air standards with WHO guidelines, phasing out the most polluting fuels, and expanding the monitoring infrastructure to capture the spatial variability the study uncovered are among the recommended steps. The researchers also acknowledge the limitations inherent in their approach: the analysis relied on district-average concentrations for a single year rather than individual exposure measurements, and it could not disentangle the independent contribution of PM2.5 from that of tobacco smoking, which remains the leading cause of lung cancer globally. Future work incorporating personal exposure monitoring, satellite-derived concentration surfaces, and multi-year averaging would sharpen the estimates considerably.

What makes the findings resonate beyond Morocco’s borders is their demonstration that air pollution is not a uniform hazard and that the communities suffering the highest proportional cancer burden are often not the ones that attract the most attention. The dusty southern towns and rural interior districts that topped the risk ranking receive far less regulatory scrutiny than the smoggy megacities of the coast, yet their residents face attributable fractions approaching 23 percent. As climate change intensifies aridity and dust generation across the Maghreb, and as urbanization accelerates vehicle fleets and energy demand, the exposure gradient documented in this study is likely to shift. The Moroccan analysis offers both a warning and a method: a warning that fine particle pollution is already carving measurable cancer burdens into communities far from any smokestack skyline, and a method, transparent, replicable, and grounded in WHO tools, by which any nation can hold its own air to account.

Subject of Research: Spatial assessment of lung cancer burden attributable to long-term PM2.5 exposure across Moroccan districts using the WHO AirQ+ model

Article Title: Spatial analysis of the burden of lung cancer attributable to long-term PM2.5 exposure in Morocco: a national assessment using the WHO AirQ+ model

Article References: Bouchriti, Y., Ait Haddou, M., Achbani, A., Rida, J., Sine, H., Lkoul, A., Gougueni, H., Acim, R., Amiha, R., & Kabbachi, B. (2026). Spatial analysis of the burden of lung cancer attributable to long-term PM2.5 exposure in Morocco: a national assessment using the WHO AirQ+ model. Environmental Monitoring and Assessment, 198(10), Article 1107. https://doi.org/10.1007/s10661-026-15942-6

Image Credits: AI Generated

DOI: 10.1007/s10661-026-15942-6

Keywords: PM2.5, lung cancer, air pollution, Morocco, AirQ+ model, attributable risk, environmental health, spatial analysis, WHO guidelines, biomass combustion, cancer epidemiology, public health